The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas
Brain tumors are the most common solid pediatric malignancy. For high-grade, recurrent or refractory pediatric brain tumors, radiation therapy (XRT) is an integral treatment modality. In the era of personalized cancer therapy, molecularly targeted agents have been designed to inhibit pathways crit...
Main Authors: | Tina eDasgupta, Daphne eHaas-Kogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00110/full |
Similar Items
-
Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway
by: Shangfeng Gao, et al.
Published: (2016-11-01) -
Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells
by: Tang S, et al.
Published: (2019-01-01) -
Expression and tumor-promoting effects of caprin-1 in human glioma
by: Li Zhang, et al.
Published: (2018-01-01) -
Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway
by: Hong Qiao, et al.
Published: (2018-06-01) -
Promises of targeted therapy for low grade gliomas in children
by: E. F. Valiakhmetova, et al.
Published: (2019-07-01)